Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-18T05:17:36.274Z Has data issue: false hasContentIssue false

6 - The clinical application of anti-D prophylaxis

Published online by Cambridge University Press:  26 October 2009

Stan Urbaniak
Affiliation:
Scottish National Blood Transfusion Service and University of Aberdeen, Aberdeen, UK
Andrew Hadley
Affiliation:
University of Bristol
Peter Soothill
Affiliation:
University of Bristol
Get access

Summary

Epidemiology

Causes and incidence of alloimmunization

Anti-D is still the commonest cause of moderate and severe haemolytic disease of the fetus and newborn (HDFN) in the developed world. Alloimmunization after pregnancy with a D-positive baby is not as frequent as might be expected from the predicted incidence of D incompatibility between father and mother (60% of Dnegative pregnant women carry a D-positive fetus). There are a number of reasons for this. First, the volume of fetal cells crossing the placenta may be too small to initiate a response. Second, ABO incompatibility between mother and fetus offers some protection. Third, the Rh phenotype of the fetus affects antigenicity. Fourth, some women appear to be better responders to a small antigenic stimulus than others. About 17% of at-risk unprotected women are immunized by an ABO compatible pregnancy. Only 8% develop anti-D in the 6 months following a first pregnancy, but a further 9% develop anti-D early in a subsequent pregnancy, indicating that they had been ‘sensitized’ by the earlier pregnancy.

Ethnic groups

About 15–17% of the UK white population is D negative, and a similar approximation can be made for the Caucasian populations of North America, Europe, Australia and New Zealand. The incidence of D negatives is about 10% in Arabs, about 5% in ethnic blacks, 4–10% in Asian Indians and less than 1% in ethnic Chinese. HDFN associated with anti-D is therefore largely a disease affecting Caucasians, and Caucasians thus form a target for cost-effective preventive prophylaxis programmes.

Type
Chapter
Information
Alloimmune Disorders of Pregnancy
Anaemia, Thrombocytopenia and Neutropenia in the Fetus and Newborn
, pp. 97 - 120
Publisher: Cambridge University Press
Print publication year: 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×